<DOC>
	<DOCNO>NCT03040128</DOCNO>
	<brief_summary>To date , neuroprotective drug demonstrate clinical efficacy intracerebral hemorrhage ( ICH ) . This study use intravenous ( IV ) minocycline ICH evaluate ( 1 ) safety/ tolerability ( 2 ) evaluate clinical efficacy</brief_summary>
	<brief_title>Use Minocycline Intracerebral Hemorrhage</brief_title>
	<detailed_description>Intracerebral hemorrhage ( ICH ) remain devastating neurological disorder high mortality poor prognosis unchanged mortality rate ( 53-59 % ) . Acute treatment option ICH remain supportive available effective drug surgical therapy . All trial far fail improve clinical outcome randomize , double-blinded trial . However , one area interest maintain integrity blood-brain-barrier ( BBB ) prevent growth vasogenic edema . Matrix metalloproteinases ( MMP ) family ubiquitous zinc-dependent endopeptidase enzyme whose primary function digestion collagen type IV , laminin , fibronectin purpose remodel extracellular basal lamina . Elevated MMP-9 pathological process associate large hematoma volume , large perihematomal edema , poor clinical outcome intracerebral hemorrhage well document animal model patient . One particular MMP-9 inhibitor gain usage cerebrovascular disease minocycline . Normally FDA-approved bacterial infection acne vulgaris , minocycline also find safe effective treatment ischemic stroke ; potential role neuroprotectant ischemic stroke currently test large , randomized , double-blinded trial . Minocycline 's beneficial role neuroprotectant may also extend ICH . By inhibit MMP-9 , minocycline may decrease BBB permeability , result less perihematomal edema decrease mass effect . Although numerous animal ICH model support minocycline 's role inhibitor MMP-9 neuroprotectant , use never study human ICH .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Inclusion criterion : 1 . Age 1880 yo 2 . Acute neurological deficit correspond ICH note head CT 3 . Glasgow Coma Scale ( GCS ) &gt; 8 4 . Onset symptom within 12 hrs 5 . &lt; 30 ml blood note initial CTH ( 30 ml hematoma volume note independent marker good poor clinical outcome ) 6 . ICH score &lt; 3 7 . English/ Spanish speaking 1 . Allergy tetracycline tetracycline analogues 2 . Pregnancy suspect pregnancy 3 . Hepatic and/or renal insufficiency ( LFTs 3x great upper limit normal ; creatinine &gt; 2 mg/dL ) 4 . Thrombocytopenia ( plt count &lt; 75,000 ) 5 . History intolerance minocycline 6 . Baseline modify Rankin score &gt; 1 7 . Stuporous comatose ( GCS &lt; 8 ) 8 . Presence concomitant serious illness would confound study , include serious psychiatric disease prior suicide attempt .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>